Journal profile · Infectious Diseases
Emerging infectious diseases
ISSN 1080-6040 · eISSN 1080-6059 · Centers for Disease Control and Prevention (CDC) · UNITED STATES · Monthly · Founded 1995
Emerging infectious diseases: CAS Zone 2 · Medicine (2025 upgraded edition, Top journal); impact factor 7.58; diamond open access (no APC); no APC; review about 1 month (community reports); community-reported acceptance: about 25%; 426 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Emerging infectious diseases is published by Centers for Disease Control and Prevention (CDC) and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Viral Infections and Vectors, Mosquito-borne diseases and control and Viral gastroenteritis research and epidemiology, together about 29.4% of its articles. Its main subfields are Infectious Diseases and Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
Recognition of new and reemerging infections and understanding of factors involved in disease emergence, prevention, and elimination. Toward this end, the journal: Investigates factors known to influence emergence: microbial adaptation and change, human demographics and behavior, technology and industry, economic development and land use, international travel and commerce, and the breakdown of public health measures. Reports laboratory and epidemiologic findings within a broader public health perspective. Provides swift updates of infectious disease trends and research: new methods of detecting, characterizing, or subtyping pathogens; developments in antimicrobial drugs, vaccines, and prevention or elimination programs; case reports. Fast and broad dissemination of reliable information on emerging infectious diseases. Toward this end, the journal: Publishes reports of interest to researchers in infectious diseases and related sciences, as well as to public health generalists learning the scientific basis for prevention programs. Encourages insightful analysis and commentary, stimulating global interest in and discussion of emerging infectious disease issues. Harnesses electronic technology to expedite and enhance global dissemination of emerging infectious disease information.
From the journal's Aims & Scope
Research area (LetPub): Infectious Diseases
Editorial board by country: none in mainland China; most named United States 36, Germany 2, France 2, Canada 2, Taiwan, China 1 (47 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Viral Infections and VectorsMedicine14.1%
- Mosquito-borne diseases and controlMedicine8.7%
- Viral gastroenteritis research and epidemiologyMedicine6.7%
- Influenza Virus Research StudiesMedicine5.6%
- Vector-borne infectious diseasesImmunology and Microbiology5.2%
- Viral Infections and Outbreaks ResearchMedicine5.2%
- Respiratory viral infections researchMedicine4.2%
- Animal Disease Management and EpidemiologyAgricultural and Biological Sciences4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Immunology | Zone 2 |
| Minor | Infectious Diseases | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Immunology | Zone 1 |
| Minor | Infectious Diseases | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Immunology | Zone 2 |
| Minor | Infectious Diseases | Zone 2 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 7.58LetPub ·
- CiteScore 2026-06
- 9.5LetPub ·
- SJR 2026-06
- 2.03LetPub ·
- SNIP 2026-06
- 1.68LetPub ·
- h-index
- 202LetPub ·
- h-index
- 332OpenAlex ·
- i10-index
- 10,848OpenAlex ·
- 2-year mean citedness
- 6.23OpenAlex ·
- Self-citation rate
- 3.8%LetPub ·
- Share of gold OA articles
- 98.66%LetPub ·
Volume
- Articles per year
- 251LetPub ·
Articles by year OpenAlex count · 15,227 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 363 | 363 | 202 |
| 2025 | 426 | 426 | 1,866 |
| 2024 | 528 | 528 | 6,143 |
| 2023 | 542 | 542 | 9,086 |
| 2022 | 514 | 514 | 10,909 |
| 2021 | 596 | 596 | 18,495 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted8
- author checklistAuthor Checklist. Required as part of every manuscript submission; confirms that authors have reviewed and agreed to meet all essential requirements.Length not stated
- author instructionsAuthor Instructions. In-depth information about authorship requirements, proprietary considerations (agreements, approvals, disclosures, permissions, etc.) edit…Length not stated
- eid subscriptionsEID Subscriptions . Sign up for monthly email notifications for EID’s table of contents and for specific article types and disease topics.Length not stated
- frequently asked questionsFrequently Asked Questions. These FAQs are compiled from customer service related emails, are updated quarterly, to help authors find answers more quickly.Length not stated
- letterPulmonary Histoplasmosis, Taiwan, 1997–2024 [PDF - 1.12 MB - 2 pages] C. Liang et al. Cite This Article EID Liang C, Hsieh CY, Lin S. Pulmonary Histoplasmosis, …Length not stated
- manuscript templateManuscript Template. This Word template provides concise guidance on how to format an article to meet submission requirements.Length not stated
- quick guide to article informationQuick Guide to Article Information. See categories of articles, numbers of figures and tables allowed, reference limits, and word counts.Length not stated
- the eid advantageThe EID Advantage. Learn why publishing in Emerging Infectious Diseases is a smart choice.Length not stated
Policy excerpts from the journal's websiteAuthorship
- Authorship
Starting on January 1, 2024, all submissions to EID should follow the requirements and guidance found in the revised Author Instructions and include a completed copy of the revised Author Checklist. Model summary
Starting on January 1, 2024, all submissions to EID should follow the requirements and guidance found in the revised Author Instructions and include a completed copy of the revised Author Checklist.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Centers for Disease Control and Prevention (CDC)
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1995
- ISSN
- 1080-6040
- Electronic ISSN
- 1080-6059
- Latest issue on the website
- Volume 32, Issue 9 (September 2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Emerging infectious diseases
What CAS zone is Emerging infectious diseases in?
In the 2025 upgraded edition of the CAS Journal Ranking, Emerging infectious diseases is in Zone 2 of Medicine, and in Zone 2 of the minor category Immunology / Infectious Diseases; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Emerging infectious diseases?
The latest impact factor listed by LetPub is 7.58; CiteScore 9.5, h-index 332.
How long does peer review take at Emerging infectious diseases?
Authors report an average review time of about 1 month; the community-reported acceptance is “about 25%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Emerging infectious diseases based?
Of the 47 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (36), Germany (2) and France (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Emerging infectious diseases?
According to LetPub and DOAJ records, Emerging infectious diseases is indexed in SCIE, Scopus and DOAJ.
Is Emerging infectious diseases open access, and what is the APC?
Emerging infectious diseases is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .